PPL Corp
PPL
33.95
+0.25
+0.74%
PPL Corp
US · PPL
#800 by market cap
Listed 1970
33.95
+0.25
+0.74%
Live - 5344 symbols - heartbeat 384s ago
· 2026-10-08 07:36
Pre-market
33.95
0.00%
After-hours
33.92
-0.09%
- Market cap
- 25.55B
- P/E (TTM)i
- 20.09
- P/Bi
- 1.70
- EPSi
- 1.59
- Div yieldi
- 3.28%
- 52W posi
- 30%
Reader sentiment
Are you bullish or bearish on PPL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.94, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.85% YoY
Margins
- Gross margin
- 42.73%
- Operating margin
- 23.55%
- Net margin
- 13.04%
Key ratios & quality
- Enterprise valuei
- 43.83B
- PEG ratioi
- 1.25
- Altman Z-Scorei
- 0.94
PEG uses trailing P/E against the 3-year net income growth rate (16.03%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.79B | 5.60B | 5.47B | 5.78B | 7.90B | 8.31B | 8.46B | 9.04B |
| Gross profit | 4.26B | 2.66B | 2.79B | 2.71B | 2.89B | 3.28B | 3.39B | 3.86B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.85B | 1.53B | 1.59B | 1.42B | 1.37B | 1.63B | 1.74B | 2.13B |
| Pretax profit | 2.29B | 919.00M | 954.00M | 521.00M | 915.00M | 924.00M | 1.12B | 1.47B |
| Tax | 458.00M | 183.00M | 314.00M | 503.00M | 201.00M | 184.00M | 228.00M | 291.00M |
| Net profit | 1.83B | 1.75B | 1.47B | -1.48B | 756.00M | 740.00M | 888.00M | 1.18B |
| Basic EPS | 3 | 2 | 2 | -2 | 1 | 1 | 1 | 2 |
| Diluted EPS | 2.58 | 2.37 | 1.91 | -1.93 | 1.02 | 1.00 | 1.20 | 1.59 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.50B | 2.03B | 2.24B | 2.27B | 2.77B | 2.11B |
| Gross profit | 1.11B | 831.00M | 1.00B | 920.00M | 1.22B | 941.00M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 678.00M | 406.00M | 569.00M | 476.00M | 745.00M | 475.00M |
| Pretax profit | 516.00M | 230.00M | 398.00M | 328.00M | 560.00M | 286.00M |
| Tax | 102.00M | 47.00M | 80.00M | 62.00M | 108.00M | 56.00M |
| Net profit | 414.00M | 183.00M | 318.00M | 266.00M | 452.00M | 230.00M |
| Basic EPS | 1 | 0 | 0 | 0 | 1 | 0 |
| Diluted EPS | 0.56 | 0.25 | 0.43 | 0.36 | 0.60 | 0.30 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.43B | 2.77B | 20.90B | 5.01B | 2.82B | 2.93B | 2.88B | 3.93B |
| Cash & ST investments | 621.00M | 815.00M | 442.00M | 3.57B | 356.00M | 331.00M | 306.00M | 1.07B |
| Inventory | 303.00M | 332.00M | 302.00M | 322.00M | 443.00M | 505.00M | 511.00M | 551.00M |
| Total assets | 43.40B | 45.68B | 48.12B | 33.22B | 37.84B | 39.24B | 41.07B | 45.24B |
| Total current liabilities | 4.56B | 4.90B | 15.06B | 2.32B | 3.79B | 3.34B | 3.33B | 4.55B |
| Short-term debt | 1.96B | 2.32B | 2.24B | 543.00M | 1.34B | 993.00M | 854.00M | 1.36B |
| Long-term debt | 20.07B | 20.72B | 13.62B | 10.67B | 12.89B | 14.61B | 15.95B | 17.99B |
| Total liabilities | 31,739,000,000.00 | 32,689,000,000.00 | 34,743,000,000.00 | 19,500,000,000.00 | 23,919,000,000.00 | 25,303,000,000.00 | 26,992,000,000.00 | 30,363,000,000.00 |
| Total equity | 11.66B | 12.99B | 13.37B | 13.72B | 13.92B | 13.93B | 14.08B | 14.88B |
| Retained earnings | 4.59B | 5.13B | 5.32B | 2.57B | 2.68B | 2.71B | 2.84B | 3.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.10B | 2.92B | 3.63B | 3.93B | 4.32B | 3.17B |
| Cash & ST investments | 312.00M | 294.00M | 1.10B | 1.07B | 1.24B | 332.00M |
| Inventory | 476.00M | 504.00M | 517.00M | 551.00M | 536.00M | 597.00M |
| Total assets | 41.81B | 42.36B | 43.94B | 45.24B | 46.30B | 46.30B |
| Total current liabilities | 3.83B | 4.98B | 4.69B | 4.55B | 4.31B | 3.50B |
| Short-term debt | 1.35B | 2.51B | 2.05B | 1.36B | 1.21B | 534.00M |
| Long-term debt | 15.94B | 15.29B | 16.94B | 17.99B | 19.02B | 19.79B |
| Total liabilities | 27,512,000,000.00 | 28,077,000,000.00 | 29,526,000,000.00 | 30,363,000,000.00 | 31,285,000,000.00 | 31,256,000,000.00 |
| Total equity | 14.30B | 14.29B | 14.41B | 14.88B | 15.02B | 15.05B |
| Retained earnings | 3.05B | 3.03B | 3.14B | 3.21B | 3.44B | 3.46B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.82B | 2.43B | 2.75B | 2.27B | 1.73B | 1.76B | 2.34B | 2.63B |
| Depreciation & amortization | 1.17B | 1.01B | 1.08B | 1.12B | 1.23B | 1.34B | 1.36B | 1.42B |
| Free cash flow | -417.00M | 184.00M | 476.00M | 297.00M | -425.00M | -632.00M | -465.00M | -1.40B |
| Dividends paid | -1.13B | -1.19B | -1.28B | -1.28B | -787.00M | -704.00M | -747.00M | -794.00M |
| Stock buybacks / issuance | 698.00M | 1.17B | 0 | -1.00B | -- | 5.00M | 2.00M | 401.00M |
| Ending cash balance | 643.00M | 660.00M | 443.00M | 3.57B | 357.00M | 382.00M | 339.00M | 1.09B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 513.00M | 602.00M | 966.00M | 548.00M | 557.00M | 583.00M |
| Depreciation & amortization | 342.00M | 353.00M | 355.00M | 366.00M | 389.00M | 389.00M |
| Free cash flow | -280.00M | -328.00M | -179.00M | -614.00M | -501.00M | -698.00M |
| Dividends paid | -190.00M | -202.00M | -201.00M | -201.00M | -202.00M | -214.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 340.00M | 318.00M | 1.12B | 1.09B | 1.25B | 339.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.28 | 14.16 | 11.14 | -10.92 | 5.46 | 5.31 | 6.33 | 8.14 |
| ROA %i | 4.30 | 3.92 | 3.13 | -3.64 | 2.13 | 1.92 | 2.21 | 2.73 |
| ROIC %i | 7.88 | 7.28 | 5.95 | -2.59 | 4.34 | 4.32 | 4.79 | 5.56 |
| 5-year avg ROE %i | 13.07 | 13.25 | 14.32 | 8.31 | 7.22 | 5.03 | 3.46 | 2.86 |
| EBIT margin %i | 41.72 | 40.53 | 39.07 | 24.88 | 18.07 | 19.13 | 21.91 | 25.22 |
| FCF / sales %i | -- | -- | -- | 5.14 | -- | -- | -- | -- |
| Current ratioi | 0.53 | 0.56 | 1.39 | 2.16 | 0.75 | 0.88 | 0.86 | 0.86 |
| Quick ratioi | 0.41 | 0.43 | 0.10 | 1.95 | 0.52 | 0.59 | 0.55 | 0.63 |
| Debt / assetsi | 50.76 | 50.45 | 32.96 | 33.74 | 37.60 | 39.77 | 40.92 | 42.77 |
| LT debt / equityi | 172.16 | 159.50 | 101.81 | 77.72 | 92.63 | 104.87 | 113.32 | 120.89 |
| Interest coveragei | 3.37 | 3.17 | 2.97 | 1.57 | 2.78 | 2.39 | 2.51 | 2.82 |
| Revenue CAGR (3Y) %i | 0.50 | -9.34 | -9.75 | -9.43 | 12.15 | 14.94 | 13.53 | 4.59 |
| Net income CAGR (3Y) %i | 38.88 | -2.81 | 9.20 | -- | -24.35 | -20.43 | -- | 16.03 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.00 | 6.96 | 7.65 | 8.14 | 8.30 | 8.62 |
| ROA %i | 2.44 | 2.40 | 2.58 | 2.73 | 2.76 | 2.85 |
| ROIC %i | 5.08 | 5.07 | 5.33 | 5.56 | 5.61 | 5.77 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.01 | 22.71 | 23.92 | 25.22 | 25.32 | 26.04 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.81 | 0.59 | 0.77 | 0.86 | 1.00 | 0.91 |
| Quick ratioi | 0.52 | 0.37 | 0.55 | 0.63 | 0.71 | 0.57 |
| Debt / assetsi | 41.34 | 42.01 | 43.21 | 42.77 | 43.71 | 43.89 |
| LT debt / equityi | 111.48 | 107.04 | 117.51 | 120.89 | 126.67 | 131.53 |
| Interest coveragei | 2.66 | 2.61 | 2.73 | 2.82 | 2.80 | 2.80 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Kentucky Regulated is the largest reported line at 42.07% of revenue, across 3 reported segments.
- No single line clears half of revenue; Pennsylvania Regulated is next at 35.24%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Kentucky Regulated42.07%
Pennsylvania Regulated35.24%
Rhode Island Regulated22.69%
Quote time 2026-10-08 07:36:50 · For reference only, not investment advice and not tailored to your situation.